Strengths and limitations of the EULAR definition for difficult-to-treat rheumatoid arthritis. [PDF]
Nagy G, Buch MH.
europepmc +1 more source
Immunometabolic and brain structural alterations mediate increased risk of brain diseases in rheumatoid arthritis patients. [PDF]
He S +10 more
europepmc +1 more source
Hepatotoxicity Risk of Isoniazid in Patients with Autoimmune Rheumatic Diseases and Prior Liver Injury Due to Disease-Modifying Antirheumatic Drugs: A Single-Center Experience and Literature Review. [PDF]
Osorio-Chávez JS +5 more
europepmc +1 more source
A case report: corneal melting after patch graft in a rheumatoid arthritis patient taking Upadacitinib: paradoxical manifestation or uncontrolled disease activity? [PDF]
Wu H, Jin X, Zhang H.
europepmc +1 more source
Total Ankle Arthroplasty in Rheumatoid Arthritis: Clinical Outcomes and Prosthesis Survivorship with Mean 8-Year Follow-up. [PDF]
Yoon YK +4 more
europepmc +1 more source
Current status and emerging trends in biological therapies for ankylosing spondylitis: A bibliometric analysis (2004-2024). [PDF]
Deng R +5 more
europepmc +1 more source
Does perioperative discontinuation of anti-rheumatic drugs increase postoperative complications in orthopedic surgery for rheumatoid arthritis? [PDF]
Ito H +21 more
europepmc +1 more source
Linking AIM2 Inflammasome Activation, Mitochondrial Dysfunction and Chronic Inflammation in Ankylosing Spondylitis. [PDF]
Boengiu CA +4 more
europepmc +1 more source
Stepwise dose reduction and discontinuation of bDMARD in rheumatoid arthritis: a prospective cohort study of flare-free population, flares, and predictive markers. [PDF]
Nozaki Y +10 more
europepmc +1 more source

